- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ruxolitinib
Total 350 results
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Celgene; Incyte CorporationActive, not recruitingMyelofibrosisUnited States
-
University of Colorado, DenverDaiichi Sankyo, Inc.CompletedDyslipidemia | HyperlipidemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in the Bone | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedEstrogen-receptor Positive Invasive Metastatic Breast CancerUnited States
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
OncotherapeuticsIncyte CorporationNot yet recruiting
-
OncotherapeuticsIncyte CorporationRecruitingMultiple MyelomaUnited States
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Assistance Publique Hopitaux De Marseille; Hôpital d'instruction des armées...Terminated
-
iOncturaActive, not recruitingMyelofibrosis | NSCLC | Uveal Melanoma | Solid Tumor, Adult | Non-Hodgkin Lymphoma, AdultUnited Kingdom, Italy
-
Lomonosov Moscow State University Medical Research...Completed
-
French Innovative Leukemia OrganisationNovartis PharmaceuticalsTerminatedEssential ThrombocythemiaFrance
-
Capital Research Institute of PediatricsUnknown
-
CTI BioPharmaPSI CRORecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of, Canada, Spain, Czechia, United States, Australia, France, Hungary, United Kingdom, Romania, Belarus, Bulgaria, Georgia, Germany, Israel, Italy, Poland, Russian Federation, Serbia, Ukraine, Bosnia and Herzegovina and more
-
Marina KremyanskayaIncyte CorporationWithdrawnMyelofibrosis | MF
-
Wake Forest University Health SciencesIncyte Corporation; Amgen; Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Blasts More Than 20 Percent of Bone Marrow Nucleated Cells | Blasts More Than 20 Percent of Peripheral Blood White CellsUnited States
-
French Innovative Leukemia OrganisationCompleted
-
Brian DrukerAbbVie; Oregon Health and Science University; Incyte CorporationActive, not recruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelofibrosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPrimary Myelofibrosis | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; Taipei Veterans... and other collaboratorsNot yet recruitingRefractory Diffuse Large B-cell Lymphoma
-
Incyte CorporationTerminated
-
Incyte CorporationCompleted
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedMyeloproliferative DiseasesUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
St. Petersburg State Pavlov Medical UniversityActive, not recruitingAcute Myeloid Leukemia | Acute Lymphoid Leukemia | Stem Cell Transplant Complications | Graft-versus-host-diseaseRussian Federation
-
Medicines for Malaria VentureNucleus Network Ltd; Southern Star Research Pty Ltd.Completed
-
Karyopharm Therapeutics IncNot yet recruitingMyelofibrosis | Moderate Thrombocytopenia
-
TASK Applied ScienceRecruitingRifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)South Africa
-
Incyte CorporationTerminatedPancreatic Cancer | Solid TumorsUnited States
-
St. Petersburg State Pavlov Medical UniversityCompletedPrimary Myelofibrosis | Myeloproliferative DisordersRussian Federation
-
AbbVieActive, not recruitingMyeloproliferative NeoplasmUnited States, Belgium, Bulgaria, Croatia, France, Germany, Italy, Japan, Serbia, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
OncotherapeuticsNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Beijing Friendship HospitalNot yet recruitingMacrophage Activation Syndrome
-
Masonic Cancer Center, University of MinnesotaRecruitingAcute-graft-versus-host DiseaseUnited States
-
The Third Affiliated hospital of Zhejiang Chinese...Recruiting
-
Shanghai General Hospital, Shanghai Jiao Tong University...Unknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMinimal Residual Disease | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals; Incyte CorporationActive, not recruiting
-
University of BirminghamNovartis; National Cancer Institute, France; MPN VoiceRecruitingPolycythemia VeraUnited Kingdom
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Malaria ConsortiumRecruiting
-
Incyte CorporationTerminatedSolid TumorsUnited States, Belgium, France
-
National Institute of Allergy and Infectious Diseases...CompletedUrinary Tract InfectionUnited States
-
Texas Tech University Health Sciences CenterUniversity of Texas Southwestern Medical Center; National Center for Research...CompletedObesity | Tuberculosis | Pharmacokinetics | MRSA | PCPUnited States
-
Peking University People's HospitalNot yet recruiting
-
Incyte CorporationCompletedPsoriasisUnited States
-
The Children's Hospital of Zhejiang University...First Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingCytokine Storm | Hemophagocytic LymphohistiocytosesChina